← The Wire
AMRXNasdaq
Amneal Pharmaceuticals, Inc.
Pharmaceutical Preparations · CIK 1723128
Amneal develops, manufactures, markets, and distributes essential medicines including generics, injectables, biosimilars, and branded pharmaceuticals
$5.17B
Market cap
$17.29
Last close
+0.3%
1D
+7.3%
5D
2.5M
Volume
Price · last 39 sessions+31.9%
May 4L $11.81 · H $17.32Jun 29
176
Total filings
May 7, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 7, 20268-KShareholder VoteMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 23, 2026DEFA14ADEFA14AApr 22, 2026DEFA14ADEFA14AApr 22, 2026DEFA14ADEFA14AApr 22, 2026DEFA14ADEFA14AApr 22, 2026DEFA14ADEFA14AApr 22, 2026DEFA14ADEFA14AApr 22, 20268-KMaterial Agreement · Results of OperationsApr 22, 2026SC 13D/ASC 13D/AMar 26, 2026DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSMar 25, 2026DEF 14ADEFINITIVE PROXY STATEMENTMar 25, 202610-K10-KFeb 27, 20268-KResults of Operations · Reg FD DisclosureFeb 27, 20268-KMaterial Agreement · New Debt / ObligationFeb 3, 20268-KCompany UpdateJan 28, 20268-KResults of Operations · Reg FD DisclosureJan 13, 202610-Q10-QNov 6, 20258-KResults of Operations · Reg FD DisclosureOct 30, 202510-Q10-QAug 7, 20258-K/AShareholder VoteAug 5, 20258-KResults of Operations · Reg FD DisclosureAug 5, 20258-KMaterial Agreement · New Debt / ObligationAug 1, 20258-KCompany UpdateJul 24, 20258-KCompany UpdateJul 21, 20258-KExecutive Change · Results of OperationsJul 21, 20258-KShareholder VoteMay 8, 202510-Q10-QMay 7, 20258-KResults of Operations · Reg FD DisclosureMay 2, 2025DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSMar 25, 2025DEF 14ADEFINITIVE PROXY STATEMENTMar 25, 20258-KExecutive ChangeMar 6, 202510-K10-KFeb 28, 20258-KResults of Operations · Reg FD DisclosureFeb 28, 20258-KResults of Operations · Reg FD DisclosureJan 15, 20258-K/AResults of Operations · Reg FD DisclosureNov 12, 202410-Q10-QNov 12, 20248-KResults of Operations · Reg FD DisclosureNov 8, 20248-KReg FD DisclosureOct 1, 202410-Q10-QAug 9, 20248-KResults of Operations · Reg FD DisclosureAug 9, 202410-Q10-QMay 8, 20248-KShareholder VoteMay 7, 20248-KResults of Operations · Reg FD DisclosureMay 3, 2024DEFA14AAMNEAL PHARMACEUTICALS, INC. - DEFA14AMar 22, 2024DEF 14AAMNEAL PHARMACEUTICALS, INC. - DEF 14AMar 22, 202410-K10-KMar 14, 20248-KResults of Operations · Reg FD DisclosureMar 1, 20248-KResults of Operations · Reg FD DisclosureJan 10, 2024SC 13GSC 13GJan 5, 20248-KDelisting Notice · Reg FD DisclosureDec 15, 20238-K/ACompany UpdateDec 15, 20238-KMaterial Agreement · New Debt / ObligationNov 14, 202310-Q10-QNov 9, 20238-KResults of Operations · Reg FD DisclosureNov 7, 20238-KResults of Operations · Reg FD DisclosureOct 23, 20238-KMaterial Agreement · Reg FD DisclosureOct 17, 202310-Q10-QAug 8, 20238-KResults of Operations · Reg FD DisclosureAug 4, 20238-KCompany UpdateMay 19, 20238-KShareholder VoteMay 12, 202310-Q10-QMay 9, 20238-KResults of Operations · Reg FD DisclosureMay 5, 20238-KResults of Operations · Reg FD DisclosureApr 17, 2023DEFA14AAMNEAL PHARMACEUTICALS, INC. - DEFA14AMar 24, 2023DEF 14AAMNEAL PHARMACEUTICALS, INC. - DEF 14AMar 24, 202310-K10-KMar 3, 20238-KResults of Operations · Reg FD DisclosureMar 2, 20238-KResults of Operations · Reg FD DisclosureJan 10, 202310-Q10-QNov 7, 20228-KResults of Operations · Reg FD DisclosureNov 4, 20228-KExecutive Change · Reg FD DisclosureSep 6, 202210-Q10-QAug 8, 20228-KResults of Operations · Reg FD DisclosureAug 5, 20228-KExecutive Change · Reg FD DisclosureAug 3, 20228-KCompany UpdateJul 19, 20228-KMaterial Agreement · Agreement TerminatedJun 2, 20228-KShareholder VoteMay 13, 2022
Insider Activity
In the 90 days to Nov 17, 2025: 2 sold $2.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 17, 2025 | Nark Ted CDirector | Sell | 50,000 | $11.72 | $586K |
| Nov 12, 2025 | Shah NikitaExecutive Vice President | Sell | 131,856 | $11.92 | $1.6M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance